Evidence map›Paper›PMID 42369821›Full record

ArticleInternational journal of women's health2026

Global Burden of Ovarian Cancer and Causal Risk Factors from 1990 to 2021: An Integrated GBD and Mendelian Randomization Analysis.

Nuo Zhang, Hualing Zhang, Hui Lin, Luanhong Wang

Abstract read
In one paragraph

Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Nuo ZhangDepartment of Gynecological Oncology, Guangdong Engineering Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics (Proposed)/Guangdong Engineering Technology Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Hualing ZhangDaytime Chemotherapy Clinic, Guangdong Engineering Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics (Proposed)/GuangDong Engineering Technology Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Hui LinDepartment of Internal Medicine, Guangdong Engineering Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics (Proposed)/Guangdong Engineering Technology Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.
Luanhong WangDepartment of Gynecological Oncology, Guangdong Engineering Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics (Proposed)/Guangdong Engineering Technology Research Center of AI-Powered Precision Cancer Diagnostics and Therapeutics, Cancer Hospital of Shantou University Medical College, Shantou, People's Republic of China.ORCID 0009-0001-9935-9720

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ovarian cancer seriously threatens women's health due to its poor prognosis. This study integrates Global Burden of Disease (GBD) and Mendelian randomization analyses, to evaluate the global burden of ovarian cancer and identify causal risk factors using large-scale GWAS summary statistics for 12 exposures. Methods: We utilized statistics from the GBD 2021 study to analyze global trends in ovarian cancer across 204 countries and territories from 1990 to 2021, along with all risk factors, high BMI and occupational exposure to asbestos, and generated forecasts for the subsequent decade. Furthermore, we employed a range of statistical genetics methods to analyze data from the genome-wide association studies, to comprehensively assess the causal relationships between variable risk factors and ovarian cancer at the individual level. Results: For all risk factors, the mortality and disability-adjusted life years (DALYs) numbers rose from 1990 to 2021 globally, while the age-standardized DALY rate (ASDR) and age-standardized mortality rate (ASMR) showed a decreasing inclination. Attributable to occupational exposure to asbestos, the mortality and DALYs numbers showed an increasing trend, while the ASMR and ASDR showed a decreasing trend. For high BMI, mortality, DALYs number, the ASMR and ASDR all demonstrated an uptrend. The projection to next decade shows a similar trend. Based on MR analyses, we forecasted that the HIP, visceral adiposity, waist circumference, alcohol intake frequency, childhood BMI, HIPadjBMI, and lifetime smoking were positively associated with ovarian cancer (HIP: OR=1.29, 95% CI: 1.13-1.48; visceral adiposity: OR=1.22, 95% CI: 1.07, 1.38, waist circumference: OR=1.28, 95% CI: 1.10-1.48). Alcohol use disorder, dried fruit intake, education, fresh fruit intake and magnesium were negatively associated with ovarian cancer (alcohol use disorder: OR=0.91, 95% CI: 0.83-0.99). Conclusion: Our research presents a detailed analysis of the overall health burden imposed by ovarian cancer. Furthermore, the findings suggest that adiposity, alcohol intake frequency and smoking may serve as significant indicators of an elevated risk of ovarian cancer. These insights are expected to assist policymakers in enhancing the implementation of prevention strategies.

Indexed as

epidemiologyglobal burdenMendelian randomizationovarian cancervariable factors

Identifiers

PMID42369821
PMCPMC13308732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.